Bioabsorbable Vascular Scaffolds Eluting with Everolimus: for Percutaneous Coronary Intervention of Patients with de-novo Coronary Artery Lesion: Our Experiences at a Tertiary Hospital. Cardiovasc. j. 2014;6(2):122-126. doi:10.3329/cardio.v6i2.18352